Get the Stockscreener App
13.09
0.83%
-0.11
After Hours:
13.15
0.06
+0.46%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $13.09, with a volume of 1.56M.
It is down -0.83% in the last 24 hours and up +20.65% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$13.20
Open:
$13.6
24h Volume:
1.56M
Relative Volume:
1.77
Market Cap:
$596.17M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-25.17
EPS:
-0.52
Net Cash Flow:
$-20.63M
1W Performance:
-0.91%
1M Performance:
+20.65%
6M Performance:
-28.12%
1Y Performance:
+49.09%
1-Day Range:
$13.00
$13.90
1-Week Range:
$12.90
$14.39
52-Week Range:
$7.34
$21.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
13.09 | 601.18M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
What markets is ENTX expanding into Is Axogen Inc. stock a good long term investment optionMarket Forecast Recommendation With Low Risk - jammulinksnews.com
Axogen, Inc. (NASDAQ:AXGN) Stock Rockets 28% But Many Are Still Ignoring The Company - 富途牛牛
Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.
Axogen gains on report of takeover interest - MSN
Why Axogen Inc. stock attracts strong analyst attentionFree Daily Profit Focused Stock Screener - Newser
What candlestick patterns are forming on Axogen Inc.Stock Portfolio Risk and Return Analysis - Newser
Price momentum metrics for Axogen Inc. explainedFree Sector Rotation Based Trading Opportunities - Newser
Chart based exit strategy for Axogen Inc.Stable Swing Setup with Safety Analysis - Newser
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Axogen stock gains on report of takeover interest (AXGN:NASDAQ) - Seeking Alpha
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Axogen Shares Plunge 2.84% as Profitability Concerns Weigh on Debt-Burdened Biotech - AInvest
Buy Signal for Axogen Inc. Stock Key Technical Indicators to WatchReal-Time Equity Price Action Analysis - Newser
How Interest Rate Changes Impact Axogen Inc. Stock PerformanceCapital Growth Plan for New Investors - Newser
Bollinger Bands Show Potential Breakout in Axogen Inc.Chart Breakout Buy Signal Detection Confirmed - beatles.ru
Axogen Inc. Added to High Probability Setup ListChart Breakout Buy Signal Detection Confirmed - beatles.ru
When Will Axogen, Inc. (NASDAQ:AXGN) Breakeven? - Yahoo Finance
What are the latest earnings results for Axogen Inc.Build wealth faster with high-performing stocks - jammulinksnews.com
Can volume confirm reversal in Axogen Inc. Free Chart Alert System With Entry Targets - Newser
How Axogen Inc. stock performs during market volatilityEntry Timing Tracker with Alert Accuracy - Newser
Is Axogen Inc. a Top Dividend Stock to Watch in 2025Secure Growth Trading Plan - metal.it
What are Axogen Inc. company’s key revenue driversGet alerts on the hottest market movers - jammulinksnews.com
Axogen Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingLow Risk Consistent Winners - Newser
What institutional investors are buying Axogen Inc. stockFree Technical Analysis Support - jammulinksnews.com
What drives Axogen Inc. stock priceExtraordinary market timing - PrintWeekIndia
AxoGen, Inc. (NASDAQ:AXGN) Stock Position Raised by New York State Common Retirement Fund - Defense World
Axogen Insiders Made A Wise Decision By Selling US$534k Worth Of Stock - 富途牛牛
Is Axogen Inc. a good long term investmentStrong return on investment - PrintWeekIndia
What analysts say about Axogen Inc. stockRobust financial gains - PrintWeekIndia
Axogen, Inc.'s (NASDAQ:AXGN) Shares Leap 29% Yet They're Still Not Telling The Full Story - simplywall.st
Axogen Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 - GlobeNewswire
Arizona State Retirement System Makes New $222,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen, Inc. to Announce 2025 Second Quarter Financial Results on August 5, 2025 - Quiver Quantitative
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):